LAMPALIZUMAB
UNII UWU93Y99R3

Substance Identification & Data

This profile provides standardized clinical and technical data for Lampalizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) UWU93Y99R3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1278466-20-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

UWU93Y99R3

CAS Registry Number

1278466-20-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LAMPALIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C123730

National Cancer Institute reference terminology for clinical and research data.

INN ID

9578

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

ZZ-139

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lampalizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LAMPALIZUMAB

Common Names & Synonyms

AFD

ANTI-FACTOR-D

ANTI-FD

LAMPALIZUMAB [INN]

LAMPALIZUMAB [USAN]

LAMPALIZUMAB [WHO-DD]

SN578B8Z9Q

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN COMPLEMENT FACTOR D) (HUMAN-MOUSE MONOCLONAL FCFD4514S HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL FCFD4514S LIGHT CHAIN

SYS